January Therapeutics
David Webb is the Technical Advisor at January Therapeutics. David has over 25 years of experience in the pharmaceutical industry, holding various positions in research and development.
Webb started their career at The Scripps Research Institute before moving to Celgene in 2003, where they served as Vice President of Research and Site Director for Celgene-San Diego. During their time at Celgene, Webb was responsible for discovering drugs and drug targets in cell signaling pathways, as well as overseeing the development of seven clinical candidates.
In 2011, Webb left Celgene to join January Therapeutics as Technical Advisor. In this role, they provide scientific and technical expertise to the company, helping to advance their pipeline of drugs.
David Webb has a PhD in Microbiology/Immunology from Rutgers University and a BA and MA in Biology from California State University, Fullerton.
This person is not in the org chart
January Therapeutics
January Therapeutics is developing next generation targeted anti-cancer therapies. Building upon the finding that protein-based nano-formulations have led to substantial improvements in the efficacy of known drugs, January is developing unique chemical matter to leverage well established anti-cancer mechanisms of action while adding new cancer targeting properties.